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The therapeutic potential of Cassia surattensis in reducing free radical-induced oxidative stress and inflammation particularly in
hepatic diseases was evaluated in this study. The polyphenol rich C. surattensis seed extract showed good in vitro antioxidant. C.
surattensis seed extract contained total phenolic content of 100.99mg GAE/g dry weight and there was a positive correlation (𝑟 >
0.9) between total phenolic content and the antioxidant activities of the seed extract. C. surattensis seed extract significantly (𝑝 <
0.05) reduced the elevated levels of serum liver enzymes (ALT, AST, andALP) and relative liver weight in paracetamol-induced liver
hepatotoxicity in mice. Moreover, the extract significantly (𝑝 < 0.05) enhanced the antioxidant enzymes and glutathione (GSH)
contents in the liver tissues, which led to decrease of malondialdehyde (MDA) level. The histopathological examination showed
the liver protective effect of C. surattensis seed extract against paracetamol-induced histoarchitectural alterations by maximum
recovery in the histoarchitecture of the liver tissue. Furthermore, histopathological observations correspondingly supported the
biochemical assay outcome, that is, the significant reduction in elevated levels of serum liver enzymes. In conclusion, C. surattensis
seed extract enhanced the in vivo antioxidant status and showed antihepatotoxic activities, which is probably due to the presence
of phenolic compounds.
1. Introduction
There is currently much interest in the therapeutic potential
of traditional and herbal therapy as an antioxidants in
reducing free radical-induced oxidative stress and inflam-
mation particularly in hepatic diseases [1]. The liver is the
primary site for metabolism of almost all drugs because it
is relatively rich in a large variety of metabolizing enzymes.
Drug induced liver injury (DILI) is one of the most frequent
causes of liver injury that poses a major clinical problem
and challenge to drug regulators [2]. Drug induced liver
injury makes up a total of 5% of all hospital admissions
and 50% of all acute liver failures [3]. Paracetamol-induced
hepatotoxicity has been linked with a number of cirrho-
sis, hepatitis, and suicide attempts cases. Paracetamol, if
taken in overdose, can cause severe hepatotoxicity that
leads to liver failure and nephrotoxicity depletion [4]. The
toxic dose of acetaminophen caused the depletion of total
glutathione (GSH) by as much as 90 percent, leading to
accumulation of toxic metabolite N-acetyl-p-benzoquinone
imine (NAPQI) which then covalently binds to cysteinyl
sulfhydryl groups in hepatic protein through the 3-position
of the benzene ring, forming NAPQI-protein adducts [5–
7].
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This causes the generation of ROS such as hydrogen
peroxide (H2O2) and hydroxyl (OH
−) radicals that affect
the cellular membrane and induce lipid peroxidation by
eliminating hydrogen from a polyunsaturated fatty acid
and subsequent liver damage or necrosis [8–10]. The toxic
metabolite formation and protein binding also cause the
dysfunction of mitochondria that leads to adenosine triphos-
phate (ATP) depletion and oxidant stress [11, 12]. Moreover,
numerous mitochondria are found in human liver cells, with
about 1000–2000 mitochondria per cell, making up 1/5 of
the cell volume [13]. Given the role of mitochondria as the
cell’s powerhouse, there may be some leakage of the high-
energy electrons in the respiratory chain to form reactive
oxygen species. This was thought to result in significant
oxidative stress in the mitochondria with highmutation rates
of mitochondrial DNA (mtDNA) [14]. A vicious cycle was
thought to occur, as oxidative stress leads to mitochondrial
DNA mutations, which can lead to enzymatic abnormalities
and further oxidative stress.Therefore, liver cells with numer-
ous mitochondria are found more vulnerable to free radical
oxidation than any other cells in the body. Hence, medicinal
plants with hepatoprotective activity are likely to make a
considerable contribution for the liver protection against the
paracetamol toxicity.
Medicinal plants are an important source of natural
antioxidant agents because of the less toxic nature and being
free from side effects compared to synthetic antioxidant [15,
16]. Most of these medicinal plants are rich in polyphenol
which have the ability to scavenge-free radicals which are
generated endogenously [17]. Polyphenols are not synthe-
sized by human being and present only in plants and some
microorganisms. Various studies exposed the antioxidant
properties of polyphenols towards human pathologies [18].
Cassia surattensis is one of the medicinal plants that is rich
in polyphenol with health benefits. The genus Cassia is well
known for its diverse biological and pharmacological prop-
erties, comprises about 600 species, and is vastly distributed
worldwide [19].The genusCassia has been used as a potential
medicinal plant since long ago [20, 21]. C. surattensis belongs
to the family Fabaceae, distributed throughout Malaysia,
and is widely grown as ornamental plants in tropical and
subtropical areas. This plant species has been traditionally
used in many countries as food products and for medicinal
uses. The bark and leaves of C. surattensis are said to be
antiblenorrhagic [22]. The decoction of the roots [23] is
commonly used to treat snake bites.The leaves are consumed
for cough and sore throat and used for both internal and
external cooling medicine. C. surattensis flowers and leaves
have been studied extensively and the therapeutic properties
such as antioxidant [24], antimicrobial [25], and antidiabetic
[26] have been reported. According to Deepak et al. [27],
C. surattensis seed showed good antioxidant, antifungal, and
antibacterial activities on bacterial and fungal cultures. A
finding by El-Sawi and Sleem [28] indicated the efficacy of
C. surattensis leaf extract as hepatoprotective agent in CCl4-
induced albino rats. Hence, present study is focused on redox
control of antioxidant and antihepatotoxic activities ofCassia
surattensis seed extract against paracetamol intoxication in
mice. The outcome from this work may add to the overall
therapeutic value of traditional and herbal medicine in
hepatic diseases.
2. Materials and Methods
2.1. Plant Sample Collection. The matured pods of C. surat-
tensis were collected from Universiti Sains Malaysia (USM),
Pulau Pinang, Malaysia. The C. surattensis plant (leaves with
flowers and pods) was authenticated by a botanist at the
Herbarium of the School of Biological Sciences, Universiti
Sains Malaysia, where a sample with voucher number 11464
has been deposited. The seeds were removed from the pods
and were washed under running tap water to remove dirt
prior to the drying process. The seeds were dried in an oven
at 50∘C. Then, the dried seeds were ground into powder and
stored in airtight bottles.
2.2. Preparation of Plant Seed Extract. The powdered seeds
(150 g) were soaked in methanol (500mL) for 7 days under
room temperature, 28∘C [29]. The whole extract was filtered
and methanol was evaporated from the filtrate by a rotary
evaporator (Buchi, Switzerland) at 40–50∘C to form a paste.
Then, the extract was dried in the oven at 60∘C to get a thick
paste form. The crude extract was sealed in Petri plate and
stored at room temperature, 28∘C.
2.3. Total Phenolic Content. The total phenolic content of
the extracts was determined using the method described
by Li et al. [30]. One mL diluted Folin-Ciocalteau reagent
was added to 1mL of methanolic seed extract. Then, 4mL
sodium carbonate and 10mL distilled water were added
to the mixture. Subsequently, the mixture was allowed to
stand 2 hours at room temperature, 28∘C. The contents
were centrifuged and absorbance was measured at 765 nm.
The samples were prepared in triplicate for each analysis
and the mean value of absorbance was obtained. The same
procedure was repeated using various concentrations of gallic
acid and a standard curve was constructed. Based on the
measured absorbance, the concentration of phenolics was
read (mg/mL) from the standard curve and the total phenolic
contents of the extract were expressed as milligrams of gallic
acid equivalents (GAE) per gram dry weight (mgGAE/g dw).
2.4. In Vitro Antioxidant Activity
2.4.1. Inhibition of 2,2-Diphenyl-1-picrylhydrazyl (DPPH)Rad-
ical Scavenging Assay. The DPPH radical scavenging activity
of C. surattensis seed methanolic extract was carried out by
previously described method by Sangetha et al. [24]. Five
mL of a 0.004% (w/v) solution of DPPH in 80% methanol
was added to 50 𝜇L of methanolic seed extract at different
concentrations (0.078, 0.16, 0.31, 0.63, 1.25, 2.50, 5.00, and
10.00mg/mL resp.). The reaction mixture was shaken vigor-
ously. Butylated hydroxytoluene (BHT, Sigma) was used as a
reference standard.The discoloration ofDPPHwasmeasured
at 517 nm after 30 minutes incubation in the dark. The lower
absorbance of the reaction mixture indicated higher free
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radical scavenging activity. All the tests were performed in
triplicate.
The percentage DPPH radical scavenging was calculated
using the following equation:
% DPPH radical scavenging =
𝐴𝑜 − 𝐴1
𝐴𝑜
× 100, (1)
where 𝐴𝑜 is the absorbance of the control and 𝐴1 is the
absorbance in the presence of the extract/standard.
2.4.2. Inhibition ofNitricOxideRadical ScavengingAssay. The
assay was conducted based on the modification method by
Chakraborthy [31]. The reaction mixture contained 1.5mL
sodium nitroprusside (10mM) in phosphate buffer saline pH
7.4 and 0.5mL of the seed extract at various concentrations
(1.95, 3.91, 7.81, 15.63, 31.25, 62.50, 125.00, 250.00, 500.00,
and 1000.00 𝜇g/mL) and incubated for 150 minutes at 25∘C.
Then, 1mL of Griess reagent (1% sulphanilamide, 0.1% naph-
thylethylenediamine dichloride and 3% phosphoric acid) was
added and the mixture was incubated for 30 minutes at room
temperature, 28∘C. The pink chromophore formed during
diazotization of nitrite ions with sulphanilamide and sub-
sequent coupling with naphthylethylenediamine dichloride
was measured at 546 nm. The activity of seed extract was
compared with ascorbic acid which was used as a reference
standard. All tests were performed in triplicate. The nitric
oxide radicals scavenging activity were calculated according
to the equation:
% Inhibition =
𝐴𝑜 − 𝐴1
𝐴𝑜
× 100%, (2)
where 𝐴𝑜 is the absorbance of the control and 𝐴1 is the
absorbance in the presence of the extract/standard.
2.4.3. Reducing Power Assay. The reducing power assay was
evaluated by the method of Oyaizu (1986) as described
by Yildirim et al. [32]. One mL seed extract at various
concentrations (0.02, 0.039, 0.078, 0.16, 0.31, 0.63, 1.25, 2.50,
5.00, and 10.00mg/mL) was mixed with 2.5mL phosphate
buffer (0.2M, pH 6.6) and 2.5mL potassium ferricyanide
[K3Fe(CN)6] (1%w/v). The mixture was incubated at 50∘C
for 20 minutes in a water bath. The reaction was stopped
by adding 2.5mL of trichloroacetic acid (TCA) solution
(10%w/v) to the mixture and then centrifuged at 3000 rpm
for 10 minutes. Then, 2.5mL of the upper layer solution
was mixed with 2.5mL distilled water and 0.5mL Ferric
chloride solution (0.1%w/v). The reaction mixture was then
incubated for 10minutes at room temperature. Absorbance of
the resultant mixture was measured at 700 nm.The increased
absorbance of the reaction mixture indicated enhanced
reducing power. Ascorbic acid was used as a reference
standard.
2.4.4. Calculation of InhibitionConcentration (IC50). TheIC50
is defined as the concentration of the sample that provides
inhibition of 50% of the initial radical concentration with
the unit, mg/mL or 𝜇g/mL. The IC50 values were calculated
from the linear regression plots of various concentrations of
methanolic extract of C. surattensis seed/reference standard
against the mean percentage of % inhibition obtained from
three replicate tests.
2.5. In Vivo Antihepatotoxic Activities
2.5.1. Animals. Fifteen adult male Swiss albino mice aged 6
to 8 weeks old and weighed 25 to 30 g were used to study
the hepatoprotective activity of C. surattensis seed extract.
The Animal Ethics Committee, Universiti Sains Malaysia,
has approved the animal study for this project (USM/Ani-
mal Ethics Approval/2013/(90)(514)). The animals were kept
under standard conditions (27 ± 2∘C, relative humidity 44–
56% and light and dark cycles of 10 hours and 14 hours, resp.)
and fed with standard mice diet and purified drinking water
ad libitum for 1 week before and during the experiments.
The animals were obtained from Animal house of Universiti
Sains Malaysia, Penang, and kept in cages under uniform
husbandry condition, standard animal diet, and drinking
water ad libitum.The foodwas withdrawn 18–24 hours before
starting the experiment. All experiments were performed in
the morning according to current guidelines for the care
of the laboratory animals and the ethical guidelines for the
investigation of experimental pain in conscious animals [33].
2.5.2. Preparation of Paracetamol Dose Regimen and Treat-
ments. The paracetamol tablets were obtained from a nearby
pharmacy. Each tablet contains 500mg of paracetamol. The
mice were administered with paracetamol at a dose of 1 g/kg
body weight (b.w.).The paracetamol wasmade into fine pow-
der using amortar and pestle.Thepowdered paracetamolwas
suspended in distilled water and was administered according
to the body weight of mice. An aqueous suspension of seed
extract was prepared in distilled water and different doses
of C. surattensis seed extract (250mg/kg b.w. and 500mg/kg
b.w.) and silymarin (200mg/kg b.w.) were administered
orally according to the body weight of mice [34].
2.5.3. Mice Groupings and Treatments. Fifteen adult male
Swiss albino mice were divided into 5 groups and each group
consists of 3 mice each (Table 1). The pretreated normal
control group received 10% dimethyl sulfoxide (DMSO)
orally. The induced group was pretreated with 10% DMSO
orally and given paracetamol once only (dose 1 g/kg b.w.)
orally. The treatment Group I received orally both doses
of 250mg/kg b.w. of C. surattensis seed extract and 1 g/kg
b.w. paracetamol, while the treatment Group II received
orally both doses of 500mg/kg bw of C. surattensis seed
extract and 1 g/kg bw paracetamol, respectively. The positive
control group was given silymarin at the dose of 200mg/kg
b.w. and paracetamol at the dose of 1 g/kg b.w. The mice
in treatment and positive control groups were pretreated
with the respective dose of seed extract/silymarin orally
once daily for 7 consecutive days. Paracetamol dose at 1 g/kg
b.w. was given to mice to induce hepatotoxicity. The oral
administration of paracetamol was performed 3 hours after
the last seed extract/silymarin administration on the 7th day
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Table 1: Mice groupings and administrated treatments.
Groups Treatment
Negative control 10% DMSO
Induced 1.0 g/kg paracetamol per bodyweight
Treatment Group I 250mg/kg seed extract per bodyweight + paracetamol
Treatment Group II 500mg/kg seed extract per bodyweigh + paracetamol
Positive control 200mg/kg silymarin per bodyweight + paracetamol
15 adult mice were divided into 5 groups (𝑛 = 3).
except for the normal control group, which received only
10% DMSO. All mice were euthanized after 48 hours after
paracetamol-induced hepatotoxicity [34].
2.5.4. Biochemical Analysis. The mice of each group were
anaesthetized with ketamine/xylazine and blood was col-
lected directly from the heart. Then centrifuged at 3000 rpm
for 15 minutes to separate the serum and kept at 4∘C for
analysis of various biochemical parameters including ALT,
AST, and ALP [35]. All the analyses were performed using
Hitachi 902 Automatic Analyzer using the adapted reagents
from Roche (Germany) at Gribbles Pathology Laboratory
Malaysia (M) Sdn. Bhd., Penang, Malaysia.
2.5.5. Determination Body Weight and Relative Liver Weight.
The mice were weighed daily during the study and the
body weights of the mice were determined and recorded.
After the mice were euthanized, the livers were isolated and
washed with saline and weights were determined by using
an electronic balance [36]. The liver weight was expressed
with respect to relative liver weight. Relative liver weight was
calculated using this formula:
Relative liver weight (%)
=
Liver organ weight × 100
Body weight
.
(3)
2.5.6. Evaluation of the Antioxidant Status in the Liver
Homogenate. Livers were perfused with saline and homog-
enized in chilled potassium chloride (1.17%) using a homog-
enizer to determine the in vivo antioxidant level in the liver
tissues.
(1) Glutathione (GSH) Activity Assay. The GSH activity
was quantified by using commercially available Glutathione
Assay Kit (Sigma-Aldrich, USA). Initially, 10mL of liver
homogenate was added and mixed properly with 150 𝜇L of
working solution consisting of 1.5mg/mL DTNB, 6U/mL
glutathione reductase, and 1x assay buffer in a 96 well-plate
before being incubated for 5min. Subsequently, 50mL of
NADPH solution with a concentration of 0.16mg/mL was
added to each well in a 96 well-plate. Finally, the absorbance
was measured by using an ELISA Plate Reader (Molecular
Devices Inc., USA) at 412 nm wavelength at 1min intervals
for 5min [37].
(2)TheMalonyldialdehyde (MDA) Assay. Each liver homoge-
nate (200 𝜇L) was diluted with 800𝜇L of PBS andmixed with
25 𝜇L of 8.8mg/mL butylhydroxytoluene and 500 𝜇L of 50%
trichloroacetic acid. The mixture was vortexed, incubated
for 2 h on ice, and centrifuged at 2000×g for 15min. The
supernatant (1mL) was transferred into a new tube and
mixed with 75𝜇L of 0.1M EDTA and 250𝜇L of 0.05-M 2-
thiobarbituric acid. The mixture was boiled for 15min and
allowed to cool to room temperature before the absorbance
was measured at 532 and 600 nm in an ELISA Plate Reader
(Molecular Devices Inc., USA) [37].
(3) Super Oxide Dismutase (SOD) Assay. Initially, a master
mixture comprised 0.1mol/L phosphate buffer, 0.15mg/mL
sodium cyanide in 0.1mol/L ethylenediaminetetraacetic acid
(EDTA), 1.5mmol/L nitroblue tetrazolium, and 0.12mmol/L
riboflavin was prepared. Afterward, 200𝜇L ofmastermixture
was added to 100 𝜇L of serially diluted liver homogenates in a
96 well-plate beforemixed thoroughly. Lastly, the absorbance
was read by using an ELISA Plate Reader (Molecular Devices
Inc., USA) at 560 nm wavelength and the SOD activity in
the liver homogenate was expressed as units SOD/mg protein
[37].
2.5.7. Histopathological Observations. The liver samples of the
mice were fixed in 10% buffered formalin. After fixation, the
livers were dehydrated in a graded series of alcohol, cleared in
xylene, and embedded in paraffinwax.Multiple 5 𝜇msections
from each block were mounted on slides. After staining with
hematoxylin and eosin (H&E), slides were examined under a
microscope for histopathological changes [34].
2.6. Statistical Analysis. Data are expressed as mean ± Stan-
dard Deviation (SD). Significance was evaluated using 𝑡-test
and one-way ANOVA test (SPSS 13.0, SPSS Inc., Chicago,
III) followed by Tukey post hoc multiple comparisons test
for unpaired values. Regression analysis was performed
to calculate the dose-response relation. Linear regression
analysis was performed to find out the correlation coefficient.
𝑝 < 0.05 was considered statistically significant.
3. Results
3.1. Extract Yield. The extraction was carried out using
matured C. surattensis seeds. The weight of powdered seeds
was 52.22 g. The weight of the seeds extract in paste form
was 14.92 g. The extraction process yielded 28.57% of C.
surattensis seeds extract.
3.2. Total Phenolic Content. The total phenolic content of the
C. surattensis seed extract was expressed as mg gallic acid
equivalent/g dryweight and calculated by using the gallic acid
standard curve equation: 𝑦 = 0.052𝑥 + 0.311 (𝑅2 = 0.992).
The total phenolic content of C. surattenis seed extract was
100.99mg GAE/g dry weight.
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Figure 1: Percentage inhibition of methanolic seed extract of C.
surattensis on DPPH free radicals compared to butylated hydrox-
ytoluene (BHT). Each value is expressed as mean ± SD (𝑛 = 3),
∗𝑝 < 0.05 compared with BHT.
3.3. Radical Scavenging Activity
3.3.1. 2,2-Diphenyl-1-picrylhydrazyl (DPPH) Radical Scaveng-
ing Assay. Figures 1 and 2 show that the dose-response
activity of DPPH radical scavenging activity of the methanol
extract of the C. surattensis seed compared to the standard
antioxidant BHT. The methanolic seed extract showed the
highest scavenging activity, 70.39% ± 0.50 at 10mg/mL, and
lowest, 12.18% ± 0.35 at 0.078mg/mL. The methanolic seed
extract exhibited concentration dependent antioxidant activ-
ity by inhibiting DPPH radical with inhibitory concentration
50% (IC50) value of 2.13 ± 1.01mg/mL and BHT was 0.31 ±
0.17mg/mL (Figures 1 and 2).
3.3.2. Nitric Oxide (NO) Radical Scavenging Assay. Dose-
dependent NO scavenging activity of the methanol extract
of the C. surattensis seed is shown in Figures 3 and 4.
The methanolic seed extract showed the highest scavenging
activity (67.60% ± 1.07) at 1000 𝜇g/mL and lowest (13.42% ±
0.13) at 1.95 𝜇g/mL. The methanolic seed extract of C.
surattensis exhibited concentration dependent antioxidant
activity by inhibiting nitric oxide radical with IC50 value of
164.06±1.13 𝜇g/mL and ascorbic acid was 22.39±0.98 𝜇g/mL
(Figure 3). The IC50 values of the ascorbic acid were com-
paratively lower than seed extract which indicates higher
antioxidant activity of ascorbic acid compared to the seed
extract (Figure 4). Previously, Parul et al. [38] demonstrated
that ascorbic acid has a strong antioxidant activity on the NO
radical.
% inhibition
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y = 30.26x + 65.37
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R2 = 0.961
y = 29.67x + 40.23
Figure 2: Inhibition effect of C. surattensis seed extract on DPPH
free radicals compared with butylated hydroxytoluene (BHT).
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Figure 3: Percentage inhibition of methanolic seed extract of C.
surattensis on nitric oxide radicals compared to ascorbic acid. Each
value is expressed as mean ± SD (𝑛 = 3), ∗𝑝 < 0.05 compared with
ascorbic acid.
3.3.3. Reducing Activity. The dose-response action for the
reducing activity of methanol extract of C. surattensis seed
is shown in Figure 5. The seed extract demonstrated reduc-
ing power activity in all the concentration tested, in a
concentration-dependent manner. The seed extract reduced
ferricyanide complex (Fe3+) to the ferrous form (Fe2+) and
this showed that the seed extract has antioxidant properties.
The methanolic seed extract showed the highest absorbance,
1.366 ± 0.0036 at 10.00mg/mL, and lowest, 0.235 ± 0.0021 at
0.02mg/mL. The higher absorbance of the reaction solution
indicates the greater reducing power and greater antioxidant
activity [39]. Ascorbic acid showed greater reducing power
than that of the C. surattensis seed extract.
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Figure 4: Inhibition effect of C. surattensis seed extract on nitric
oxide radicals compared with ascorbic acid.
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Figure 5: Reducing power of methanolic seed extract ofC. suratten-
sis compared to ascorbic acid. Each value is expressed as mean ± SD
(𝑛 = 3), ∗𝑝 < 0.05 compared with ascorbic acid.
3.4. In Vivo Antihepatotoxic Activities
3.4.1. Determination of BodyWeight and Relative LiverWeight.
Table 2 shows that the average body weights of the exper-
imental animals were not affected by paracetamol, silymarin,
and C. surattensis seed extract. The paracetamol administra-
tion caused a significant increase in the average liver weight
of the paracetamol-induced group compared to the negative
control group. The pretreatment with C. surattensis seed
extract, at doses of 250 and 500mg/kg b.w., and silymarin at
a dose of 200mg/kg bw significantly reduced the increased
liver weight in paracetamol-induced group. A significant
elevation of relative liver weight was seen in paracetamol-
induced group, 8.15 ± 0.35%, when compared to the negative
control group, 5.82 ± 0.31%, indicating the paracetamol-
induced hypertrophy of these tissues. By contrast, C. surat-
tensis seed extract, at dose of 250mg/kg bw and 500mg/kg
bw, and silymarin at a dose of 200mg/kg bw in combination
with paracetamol significantly (𝑝 < 0.05) reduced the value
of the relative liver weights to 5.99 ± 0.18%, 6.03 ± 0.47%,
and 6.12±0.41%, respectively, suggesting the possibility of C.
surattensis seed extract to give protection against liver injury
upon paracetamol administration.
3.4.2. Biochemical Analysis. The effect of C. surattensis seed
extract on liver marker enzymes (ALT, AST, and ALP) is
displayed in Table 3. The data exhibited that the negative
control group demonstrated a normal range of ALT, AST,
andALP levels. However, paracetamol administration caused
a significant elevation in the ALT, AST, and ALP levels to
1689±102.14U/L, 2998±189.22U/L, and 341.51±38.11U/L,
respectively, compared to the negative control group with
pretreated 10% DMSO. A single oral dose of paracetamol
at 1 g/kg bw caused a drastic increase in the serum liver
marker enzyme activities of ALT, AST, and ALP [40], indi-
cating an acute hepatotoxicity induced by administration of
paracetamol. According to the Table 3 data, the biochemical
parameters of the C. surattensis seed extract pretreated group
were greater than those of the negative control group (𝑝 <
0.05), but it showed much lower levels of ALT, AST, and
ALP than the paracetamol-induced group; that is, the extract
treatment significantly reduced the previously elevated levels
of ALT, AST, and ALP in liver tissue of hepatotoxic mice.
3.4.3. The Antioxidant Status in the Liver Tissues. The in
vivo antioxidant level in the liver tissues of paracetamol-
intoxicated mice pretreated with C. surattensis seed extract
was evaluated by various antioxidant assays, namely, GSH
assay, SOD assay, and MDA assay (Table 4). The data exhib-
ited that the negative control group revealed a normal range
ofGSH, SOD, andMDA levels, while the paracetamol-treated
group displayed elevated levels of MDA and with decreased
level of GSH and SOD, approving that paracetamol triggered
liver injury at higher doses. However, the C. surattensis
seed extract or silymarin pretreatment significantly elevated
the previously dropped levels of GSH and SOD which
led to depletion of the MDA levels in liver tissue. These
findings clearly demonstrating the in vivo antioxidant activity
C. surattensis seed extract at the dose of 250mg/kg and
500mg/kg by significantly reversing (𝑝 < 0.05) the effect
produced by the paracetamol triggered liver injury.
3.4.4. Histopathological Observation. To further explore the
biochemical analysis findings, histopathological observation
was conducted on liver tissue. Liver sections taken from
paracetamol-induced mice (Figure 6) had severe necro-
sis, vacuolar degeneration, loss of cellular boundaries, and
obstruction of sinusoids, and hepatocytes were disrupted
and showed hypertrophy compared to the healthy negative
control group. The accumulation of neutrophils was also
seen in the central vein. The neutrophils act as an indicator
of the occurrence of cell damage as they are absent in
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Table 2: Effect of C. surattensis seed extract on the body and liver weight of mice in paracetamol induced hepatotoxicity.
Groups Dose (mg/kg) Body weight,BW (g)
Liver weight,
LW (g)
Relative liver
weight (%)
(LW/BW)
10% DMSO pretreated negative
control — 39.88 ± 3.15 2.32 ± 3.01 5.82 ± 0.31
Paracetamol-induced — 38.99 ± 5.12∗∗ 3.18 ± 5.01∗∗ 8.15 ± 0.35∗∗
Silymarin + paracetamol 200.00 41.51 ± 3.12∗ 2.54 ± 2.82∗ 6.12 ± 0.41∗
Seed extract + paracetamol 250.00 39.85 ± 3.12∗ 2.39 ± 3.08∗ 5.99 ± 0.18∗
Seed extract + paracetamol 500.00 40.08 ± 3.48∗ 2.42 ± 3.40∗ 6.03 ± 0.47∗
Results are expressed in means ± SD (𝑛 = 3).
∗
𝑝 < 0.05 compared with paracetamol-induced group.
∗∗
𝑝 < 0.05 compared with 10% DMSO pretreated negative control group.
Table 3: Effect of C. surattensis seed extract on ALT, AST, and ALP (U/L) levels of mice in paracetamol-induced hepatotoxicity.
Groups Dose (mg/kg) ALT (U/L) AST (U/L) ALP (U/L)
10% DMSO pretreated negative control — 16.72 ± 2.31 89.89 ± 4.12 114.3 ± 4.22
Paracetamol-induced group — 1689 ± 102.14a 2998 ± 189.22a 341.51 ± 38.11a
Silymarin + paracetamol 200.00 601.1 ± 184.47
ab
921.3 ± 298.21ab 185.47 ± 12.21ab
Seed extract + paracetamol 250.00 1105 ± 204.28ab 2031 ± 388.12ab 271.55 ± 27.32ab
Seed extract + paracetamol 500.00 801.43 ± 99.21ab 1389 ± 212.33ab 231.12 ± 11.17ab
Results are expressed in means ± SD (𝑛 = 3).
a
𝑝 < 0.05 compared with 10% DMSO pretreated negative control group.
ab
𝑝 < 0.05 compared with paracetamol-induced group.
SS
N
H
CV
50𝜇m
Figure 6: Light microphotograph of negative control liver. (H: hep-
atocytes; N: nucleus; SS: sinusoid; CV: central vein). Magnification:
40x.
normal healthy cells (Figure 7). Histopathological analysis
showed that silymarin as well as the seed extract at a
dose of 500mg/kg b.w. significantly improved the degree
of hepatocytes degeneration and necrosis in paracetamol-
induced mice.
The hepatocyte nucleases are at a recovery stage and there
are very minimal numbers of neutrophils surrounding the
central vein.
The pretreated group with seed extract at a dose of
500mg/kg b.w. (Figure 9) and silymarin at a dose of 200mg/
kg b.w. (Figure 10) was very close to the negative control
group which showed intact liver cells. Histopathological liver
sections of control group showed normal cellular structure
and clear central vein, and hepatic cells were distinct and
CV
DS
NP
FN
50𝜇m
Figure 7: Light microphotograph of paracetamol-induced liver.
(NP: neutrophil; DS: dilated sinusoid; FN: focal necrosis; CV: central
vein). Magnification: 40x.
separated by sinusoidal spaces. The seed extract at a dose of
250mg/kg b.w. did not show significant improvement over
the effect of paracetamol on the liver (Figure 8). Though the
extent of hepatocytes degeneration was a little lower than in
the paracetamol-induced group, liver architecture (necrosis)
was slightly improved.
4. Discussion
4.1. Total Phenolic Content. This study showed that C. surat-
tensis seed extract contained favourable amount of phenolic
compounds. A few studies have reported that C. surattensis
plant parts possess a significant total phenolic content. For
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Table 4: Effect of C. surattensis seed extract on oxidative status in paracetamol-induced hepatotoxicity mice liver tissue.
Groups Dose (mg/kg) GSH (mg/mgprotein)
SOD (U/mg
protein)
MDA (nmol/mg
protein)
10% DMSO pretreated negative control — 4.13 ± 0.12 120.82 ± 1.53 1.45 ± 0.11
Paracetamol-induced — 2.35 ± 0.05 50.07 ± 1.22∗∗ 5.04 ± 0.08∗∗
Silymarin + paracetamol 200.00 4.40 ± 0.04 136.69 ± 1.31∗ 1.64 ± 0.01∗
Seed extract + paracetamol 250.00 3.80 ± 0.01 108.56 ± 3.51∗ 1.87 ± 0.08∗
Seed extract + paracetamol 500.00 4.21 ± 0.09 130.34 ± 1.00∗ 1.68 ± 0.05∗
Results are expressed in means ± SD (𝑛 = 3).
∗
𝑝 < 0.05 compared with paracetamol-induced group.
∗∗
𝑝 < 0.05 compared with 10% DMSO pretreated negative control group.
CV
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Figure 8: Light microphotograph of liver cells of mice treated with
C. surattensis (250mg/kg) (H: hepatocytes; N: nucleus; SS: sinusoid;
CV: central vein). Magnification: 40x.
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Figure 9: Light microphotograph of liver cells of mice treated with
C. surattensis (500mg/kg) (H: hepatocytes; N: nucleus; SS: sinusoid;
CV: central vein). Magnification: 40x.
example, Sangetha et al. [24] reported that phenolic com-
pounds were found in flower, stem, leaves, and pod of C.
surattensis extracts and among the plant parts, only the flower,
stem, and leaves ofC. surattensis extracts showed a significant
high content of total phenolics. Chew et al. [41] have reported
that the flowers ofC. surattensis extract contain total phenolic
content of 3330 ± 309mg GAE/100 g.
The result of the present study clearly indicated that the
methanol extract ofC. surattensis seed exhibited the presence
of phenolic compounds and there was a strong positive
correlation with the DPPH radical scavenging activity (𝑟 =
0.968) and NO radical scavenging activity (𝑟 = 0.979).
The same relationship was also observed between phenolics
CV
SS
H
N
50𝜇m
Figure 10: Light microphotograph of liver cells of mice treated
with silymarin (H: hepatocytes; N: nucleus; SS: sinusoid; CV: central
vein). Magnification: 40x.
and antioxidant activity in Sea Buckthorn extracts [42].
Kaneria et al. [43] reported that there are high correla-
tion between phenolic contents and antioxidant activities of
some medicinal plant extracts such as Azadirachta indica,
Hemidesmus indicus, Manilkara zapota, Psoralea corylifolia,
Rubia cordifolia, and Tinospora cordifolia. These show that
the presence of a significant amount of total phenolic content
in the seed extract might effectively inhibit radicals and
contribute directly to the effective antioxidant activities.
The phenolic compound in plant donates their hydrogen
atoms from their hydroxyl groups to radicals and form a
stable phenoxyl radical and this reaction contributes to their
antioxidant activity [44].
4.2. Radical Scavenging Activity
4.2.1. 2,2-Diphenyl-1-picrylhydrazyl (DPPH) Radical Scaveng-
ing Assay. The DPPH radical is regularly used as a substrate
to evaluate the antioxidant activity of medicinal plant; it is a
stable free radical that can receive an electron to become a
stable molecule. The C. surattensis seed extract with higher
concentration showed higher bleaching ability of the DPPH∙
solution with greater hydrogen atom donating activity and
higher antioxidant activity. The antioxidant activity of the
extractmight be attributed to the hydrogendonating ability of
the phenolic hydroxyl groups [45, 46].TheDPPH scavenging
activities of C. surattensis seed extracted with acetone have
been reported in previous study by Deepak et al. [27].
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According to the study, acetone extract showed maximum
antioxidant activity, 76.11% than other extracts (methanol,
chloroform) in comparison to standard drug, ascorbic acid.
4.2.2. Nitric Oxide (NO) Radical Scavenging Assay. Nitric
oxide (NO) is a key chemical facilitator involved in the
regulation of various physiological processes. Higher con-
centration of NO is related with numerous diseases. Oxygen
molecules react with the excess amount of NO to generate
nitrite and peroxynitrite anions, which eventually act as
free radicals [47]. The results of this study indicate that
all the concentrations of C. surattensis seed extract and
ascorbic acid tested have noticeable inhibition effect on
nitric oxide radicals. The seed extract exhibited antioxidant
activity through competing with oxygen to scavenge for the
nitrite radical that was generated from sodium nitroprusside
(SNP) at physiological pH in an aqueous environment.
The C. surattensis seed extract acts as a potent antioxidant
and donate protons to the nitrite radical. This decreased
the absorbance and increased the percentage of inhibition.
The decrease in absorbance and increase in percentage of
inhibition were used to measure the extent of nitrite radical
scavenging and antioxidant activity [48].The NO scavenging
activity of phenolic compounds is known [49–51], and this
suggests that these compounds in the seed extract might
contribute to the NO scavenging activity observed in this
study.
4.2.3. Reducing Activity. Reducing power assay is commonly
used to assess the capability of a natural antioxidant to
donate an electron [52]. This finding of this study affirms
the reducing power of C. surattensis seed extract. It was
hypothesized that the reducing power of C. surattensis seed
extract might be due to their electron-donating ability and
higher amount of reductants contains. Electrons or hydrogen
atoms might react with free radicals to stabilize or transform
the free radicals into more stable and nonreactive products
subsequently blocking the free radical chain reactions [53,
54].Therefore,C. surattensis seed extract could act as electron
donors to free radicals and then dismiss the free radical chain
reactions.
4.3. In Vivo Antihepatotoxic Activities
4.3.1. Determination of BodyWeight and Relative LiverWeight.
The body weight of the mice in this study was not affected by
the treatment of paracetamol, silymarin, and C. surattensis
seed extract. This finding was parallel with the findings by
Saad et al. [55] on the failure of thioacetamide to cause
changes in body weight of rats in acute liver injury study.
The increase in the liver weight and relative liver weight of
paracetamol-induced liver hepatotoxicity group compared to
negative control, silymarin and C. surattensis seed extract
(doses of 250mg/kg b.w. and 500mg/kg b.w.), pretreated
groups might be associated with the blocking of hepatic
triglyceride secretion into plasma or might be due to the very
large increase in liver hemoglobin [56]. On the other hand,
the pretreatment with silymarin and seed extract prevented
the increase in liver weight and relative liver weight when
compared to paracetamol-induced group, which proved the
significant hepatoprotective effect.
4.3.2. Biochemical Analysis. Paracetamol induced mice liver
damage in this study because of the formation of toxic
metabolite, NAPQI, which is initially detoxified by con-
jugation with glutathione to form mercapturic acid [57].
The overdose of paracetamol used in this study caused the
glutathione content of hepatocytes exhausted and the hepa-
tocytes become vulnerable to the noxious effects of NAPQI
resulting in liver cell necrosis or liver failure that eventually
increased the ALT and AST levels [58, 59] which may explain
the findings of this study. It was concluded that a single dose
of paracetamol had caused damage to the parenchymal cell
in the liver that leads to the leakage of the aminotransferases
(ALT and AST) into the blood serum, resulting in increased
of its concentrations.The aminotransferases that are released
into the blood circulation when there is hepatic necrosis
making the enzymes measurable in serum [60–62].
However, pretreatment of high dose of C. surattensis seed
extract at 500mg/kg b.w. and silymarin at 200mg/kg b.w.
exhibited an ability to counteract the toxic effect of paraceta-
mol by decreasing the level of these enzymes. The pretreat-
ment of C. surattensis seed extract at a dose of 250mg/kg
b.w. caused a slight decrease in the elevated serum liver
enzymes. The results of this study supported the generally
accepted view that serum levels of aminotransferases return
to normal levels with the healing of hepatic parenchyma and
regeneration of hepatocytes [63, 64]. The decrease in AST
and ALT levels by the seed extract was also an indication of
stabilization of plasma membrane as well as repair of hepatic
tissue damage caused by paracetamol.
The pretreatment with the 250mg/kg b.w. dose of seed
extract slightly reduced the elevated serum liver enzyme
levels but not as effective as the treatment with 500mg/kg
b.w. dose of the seed extract. This proved that C. surattensis
seed extract at higher dose, 500mg/kg b.w., showed a better
hepatoprotective effect compared to the dose at 250mg/kg
b.w. This might be because the amount of antioxidant
polyphenol compound(s) in the extract which render the
free radical scavenging activity present at higher dose in
500mg/kg b.w. compared with 250mg/kg b.w. dose of C.
surattensis seed extract. Interestingly, the in vitro antioxidant
activity study showed that the C. surattensis seed extract
exhibited a concentration dependent activity which supports
this explanation.
This study also showed that in mice group with
paracetamol-induced liver hepatotoxicity, the ALT and AST
levels were elevated more compared to the lesser increase
in the ALP level. This finding indicated that paracetamol
caused cell necrosis at a single dose of 1 g/kg b.w. as cell
necrosis involves the initial increase of ALT and AST and
modest increase in ALP. The ratio of ALT/AST : ALP plays
an important role in the determination of the types of liver
damage by hepatotoxins. The ratio is greater than or equal to
five for cell necrosis injury compared to if the ratio is less than
or equal to two for cholestasis injury.
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4.3.3. The Antioxidant Status in the Liver Tissues. The ROS
induced oxidative stress inside the cells triggered damage
to hepatic parenchymal cells leading to hepatic injury [65].
The raise of ROS levels related with hepatic injury is due to
high generation of ROS and reduced scavenging potential
of the cells intrinsic antioxidants such as GSH and SOD
[65]. Moreover, ROS may cause membrane damage by lipid
peroxidation, andMDA is one of the final products of polyun-
saturated fatty acids peroxidation in the cells [66]. In this
study, paracetamol-induced liver hepatotoxicity significantly
reduced the levels of SOD and GSH and elevated the level of
MDA, which is a marker of lipid peroxidation, compared to
negative control. The overproduction of NAPQI by overdose
of paracetamol caused the glutathione content of hepatocytes
exhausted and resulting in the reduction ofGSH levels in liver
tissue [58, 59]. The C. surattensis seed extract pretreatment
was found increased in the level of intrinsic antioxidants
such as GSH and SOD, with reduction in the elevated
level of MDA, caused by the paracetamol-induced liver
hepatotoxicity. Silymarin also caused significant favourable
effects on the levels of GSH, SOD, and MDA relative to
the paracetamol-induced group. These results propose that
C. surattensis seed extract caused hepatoprotective activity
linked with the improvement of in vivo antioxidant activity.
4.3.4. Histopathological Observation. Themethanolic extract
of C. surattensis seeds showed significant hepatoprotective
activity on paracetamol-induced liver toxicity when adminis-
tered at a high dose of 500mg/kg orally.Thehistopathological
liver sections of C. surattensis seed extract (dose 500mg/kg
b.w.) pretreated group showed a comparable results to the
silymarin pretreated group (dose 200mg/kg b.w.) in recover-
ing the paracetamol-induced histopathological lesions.These
findings suggest the protection ability of 500mg/kg b.w. dose
of C. surattensis seed extract on membrane fragility and thus
decreased the leakage of the serum liver enzymes into the
blood circulation as observed in this study.
The seed extract which exhibited a concentration depen-
dent activity was not effective in recovering histopathological
lesions at a dose of 250mg/kg b.w. as C. surattensis seed
extract is more effective at higher concentration. The liver
histopathological analysis was positively concomitant with
the biochemical analysis of this study. The macroscopic
appearance of the paracetamol-induced liver showed broad
areas of necrosis that helps the leakage of the serum liver
enzymes into the blood stream, and this explains the rise
in AST, ALT, and ALP in the blood. The hepatotoxic effect
of paracetamol is mainly due to generation of free radicals
following the depletion of endogenous antioxidants such as
glutathione [67]. Therefore, the herbal green C. surattensis
seed antioxidant activity is effective in treating paracetamol-
induced liver hepatotoxicity by scavenging the free radicals
generated by the reaction of paracetamol.
In the present study, the C. surattensis seed extract was
administrated at 250mg/kg b.w. (low dose) and 500mg/kg
b.w. (high dose) based on the finding on acute oral toxicity
of C. surattensis flower methanolic extract on Swiss albino
mice. No sign of toxicity in mice was reported in the
study conducted by Sumathy et al. [68]. According to the
OECD guidelines for testing of chemicals 420 for testing
of chemicals [69], animals should only be administrated a
single dose of 5000mg/kg. Hence in this study, the high dose
of 500mg/kg bw was selected as 1/10 of the dose that was
used in the acute oral toxicity study (5000mg/kg) and the
low dose of 250mg/kg b.w. was 2 times reduction of the
high dose. Moreover, there were several studies that used
doses of 250mg/kg b.w. and 500mg/kg b.w. to evaluate the
hepatoprotective activity of plants [34, 70].
The methanolic extract of C. surattensis seeds in this
study showed a good scavenging activity of DPPH and
nitric oxide radicals. Hence, the in vitro findings further
explained the potential ofC. surattensis seed hepatoprotective
activity in paracetamol-induced liver toxicity in mice and
proved that the hepatoprotective activity may be due to the
observed redox control of antioxidant activity ofC. surattensis
seeds. Similar hepatoprotective activity of C. surattensis leaf
extract was also determined in the previous study designed
to investigate the effect of ethanolic extract of C. surattensis
leaf on CCl4-induced liver toxicity in rat. The results of
the previous study suggested that C. surattensis leaf extract
significantly reduced the elevated levels of AST,ALT, andALP
in serum which indicates the efficacy of the leaf extract as
a redox control hepatoprotective agent [28]. These current
histopathological findings further verified the redox control
antihepatotoxic activities of C. surattensis seed extract in
paracetamol-induced liver toxicity in mice model.
5. Conclusions
In conclusion, the results of the present study strongly sug-
gested thatC. surattensis seed has redox control of antioxidant
and antihepatotoxic activities at lower dose by enhancing
antioxidant activity and protecting the liver from the toxic
effect of the hepatotoxic agents.
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